Skip to main content

Hepatoprotective Effect of GanKang Granula Against Hepatic Damage in Rats and Mice

Buy Article:

$113.00 plus tax (Refund Policy)


GanKang Granula, originally a traditional Chinese medical complex in decoction form, has been employed to treat chronic hepatitis B efficiently for years in China. In this study, we evaluated the toxicological properties and preliminary pharmacodynamic action of GanKang Granula for its further development. We investigated its acute toxicity, long-term toxicity, and effect on liver damage induced by CCl4 and Bacillus Calmette-Guerin plus lipopolysaccharide. The maximum tolerance dose was 20 g/kg in both male and female mice, but the half lethal dose was undetectable. All three levels of GKG experimental groups (13.284, 6.642 and 2.214 g/kg) showed no long-term toxic effect. The experiments carried on injured model indicated that GanKang Granula could reduce damages caused by CCl4 and Bacillus Calmette-Guerin plus lipopolysaccharide. The results proved that GanKang Granula had an efficient hepatoprotective effect and strong immunologic enhancement. In conclusion, GanKang Granula is an efficient hepatoprotective medicine with low toxic side effects.


Document Type: Research Article


Publication date: 2011-11-01

More about this publication?
  • ADVANCED SCIENCE LETTERS is an international peer-reviewed journal with a very wide-ranging coverage, consolidates research activities in all areas of (1) Physical Sciences, (2) Biological Sciences, (3) Mathematical Sciences, (4) Engineering, (5) Computer and Information Sciences, and (6) Geosciences to publish original short communications, full research papers and timely brief (mini) reviews with authors photo and biography encompassing the basic and applied research and current developments in educational aspects of these scientific areas.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more